<span item_type="fundamental" item_id="bdf89319dc6f3acd61b2252817658d5c" counter_id="ST/US/PCTTW" env="prod"></span><span item_type="announcement" item_id="546907529763752065" env="prod"></span><p>Revenue: As of FY2025 Q2, the actual value is USD 1.65 M.</p><p>EPS: As of FY2025 Q2, the actual value is USD -0.81.</p><p></p><h3>Segment Revenue</h3><ul><li>Revenues: $1.7 million for the three months ended June 30, 2025, and $3.2 million for the six months ended June 30, 2025.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1830033/000095017025105036/pct-20250630.htm"></span></li></ul><h3>Operational Metrics</h3><ul><li>Cost of Operations: $30.0 million for the three months ended June 30, 2025, compared to $22.2 million for the same period in 2024. For the six months ended June 30, 2025, cost of operations was $53.3 million, compared to $43.4 million for the same period in 2024.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1830033/000095017025105036/pct-20250630.htm"></span></li><li>Research and Development Expenses: $1.4 million for the three months ended June 30, 2025, compared to $1.6 million for the same period in 2024. For the six months ended June 30, 2025, research and development expenses were $2.9 million, compared to $3.4 million for the same period in 2024.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1830033/000095017025105036/pct-20250630.htm"></span></li><li>Selling, General and Administrative Expenses: $15.9 million for the three months ended June 30, 2025, compared to $16.1 million for the same period in 2024. For the six months ended June 30, 2025, selling, general and administrative expenses were $30.3 million, compared to $32.1 million for the same period in 2024.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1830033/000095017025105036/pct-20250630.htm"></span></li><li>Operating Loss: $45.6 million for the three months ended June 30, 2025, compared to $39.9 million for the same period in 2024. For the six months ended June 30, 2025, operating loss was $83.3 million, compared to $78.9 million for the same period in 2024.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1830033/000095017025105036/pct-20250630.htm"></span></li><li>Net Loss: $144.2 million for the three months ended June 30, 2025, compared to $48.2 million for the same period in 2024. For the six months ended June 30, 2025, net loss was $135.4 million, compared to $133.8 million for the same period in 2024.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1830033/000095017025105036/pct-20250630.htm"></span></li></ul><h3>Cash Flow</h3><ul><li>Net Cash Used in Operating Activities: $75.6 million for the six months ended June 30, 2025, compared to $79.6 million for the same period in 2024.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1830033/000095017025105036/pct-20250630.htm"></span></li><li>Net Cash (Used in)/Provided by Investing Activities: - $23.6 million for the six months ended June 30, 2025, compared to $23.9 million for the same period in 2024.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1830033/000095017025105036/pct-20250630.htm"></span></li><li>Net Cash Provided by/(Used in) Financing Activities: $355.6 million for the six months ended June 30, 2025, compared to - $223.3 million for the same period in 2024.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1830033/000095017025105036/pct-20250630.htm"></span></li></ul><h3>Unique Metrics</h3><ul><li>Change in Fair Value of Warrants: $82.3 million for the three months ended June 30, 2025, compared to - $4.3 million for the same period in 2024. For the six months ended June 30, 2025, change in fair value of warrants was $25.6 million, compared to $9.6 million for the same period in 2024.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1830033/000095017025105036/pct-20250630.htm"></span></li><li>Loss on Debt Extinguishment: $0 for the three months ended June 30, 2025, compared to $0 for the same period in 2024. For the six months ended June 30, 2025, loss on debt extinguishment was $0, compared to $21.2 million for the same period in 2024.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1830033/000095017025105036/pct-20250630.htm"></span></li></ul><h3>Future Outlook and Strategy</h3><h4>Core Business Focus</h4><ul><li>Thailand Facility: Construction of a 130.0 million pound polypropylene recycling facility in Rayong, Thailand, expected to begin in the second half of 2025 and become operational in mid-2027.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1830033/000095017025105036/pct-20250630.htm"></span></li><li>Antwerp, Belgium Facility: Construction of a 130.0 million pound polypropylene recycling facility, expected to receive required permits in 2026 and become operational in 2028.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1830033/000095017025105036/pct-20250630.htm"></span></li><li>Augusta, Georgia Facility: Construction of a 300.0 million pound multi-line purification facility, with construction expected to begin in mid-2026 and the first purification line operational in 2029.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1830033/000095017025105036/pct-20250630.htm"></span></li></ul><h4>Non-Core Business</h4><ul><li>FDA LNO Submission: Received an additional FDA LNO in July 2025, expanding process conditions for PureFive™ resin production, allowing for greater flexibility and reduced energy usage in the purification process.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1830033/000095017025105036/pct-20250630.htm"></span></li></ul><h4>Priority</h4><ul><li>Revenue Growth: The Company is in various stages of customer application trials, which is anticipated to generate revenue growth in future periods.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1830033/000095017025105036/pct-20250630.htm"></span></li><li>Operational Efficiency: The Company is focusing on improving operational efficiency and reducing production costs through the construction of new facilities and the expansion of process conditions for PureFive™ resin production.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1830033/000095017025105036/pct-20250630.htm"></span></li></ul>

PureCycle Tech - CW26 | 10-Q: FY2025 Q2 Revenue: USD 1.65 M